Fabrication of Vascularized Bone Flaps with Sustained Launch of Recombinant Human Bone Morphogenetic Protein-2 and Arteriovenous Bundle.
- It’s a frequent therapy technique within the clinic to transplant a vascularized bone flap for a big bone defect. But it surely is tough for peripheral blood vessels to develop into the central area of a big bone assemble.
- On this examine, we fabricated a vascularized bone flap from a three-dimensional (3D)-printed biodegradable poly(lactide-co-glycolide) (PLGA)/β-tri-calcium phosphate (β-TCP) scaffold utilizing the mix of an arteriovenous (AV) bundle and recombinant human bone morphogenetic protein-2 (rhBMP-2).
- A degradable porous PLGA/β-TCP scaffold was ready by adopting 3D plotting and a low-temperature deposition approach. rhBMP-2 chitosan microspheres (CMs) have been fabricated and loaded into the scaffolds to induce ectopic bone formation.
- In Group SBV (scaffold+rhBMP-2+vessel), a femoral AV bundle was implanted into the central tunnel of the composite earlier than embedding into intramuscular pockets. In Group SB (scaffold+rhBMP-2), the composite was immediately implanted into intramuscular pockets.
- Bone formation was evaluated by imaging evaluation (X-rays and microcomputed tomography) and histological evaluation (Hematoxylin and Eosin staining and Masson staining) after four and 12 weeks, respectively.
- Vascularization was additionally assessed by imaging evaluation (Microfil angiography) and histological evaluation (CD31 immunohistochemical staining). The 3D-printed PLGA/β-TCP scaffold had good cytocompatibility.
- Ectopic bone formation within the scaffold might be efficiently induced by the managed launch of rhBMP-2 by CMs. Evaluating teams SBV and SB, vascularization of the composite was considerably enhanced by AV bundle implantation at four and 12 weeks.

stat-2
- Furthermore, rhBMP-2-induced bone formation was additionally considerably improved by the AV bundle at four and 12 weeks.
- The AV bundle not solely improved vascularization and bone formation of the assemble, but additionally offered an outlined vascular axis to attach with the vascular system of the bone defect by microsurgical methods.
- It offered a brand new potential therapy technique to restore massive bone defects, particularly for these with low vascular provide.
Pseudo-Pedicle Heterotopic Ossification From Use of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) in Transforaminal Lumbar Interbody Fusion Cages.
We carried out a examine to find out the frequent traits of sufferers who developed radiculopathy signs and corresponding heterotopic ossification (HO) from transforaminal lumbar interbody fusions (TLIF) utilizing recombinant human bone morphogenetic protein 2 (rhBMP-2).
HO can come up from a disk house with rhBMP-2 use in TLIF.
Formation of bone round nerve roots or the thecal sac could cause a radiculopathy with a constant sample of signs. We recognized 38 sufferers (26 males, 12 females) with a imply (SD) age of 50.8 (7.5) years who developed radiculopathy signs and corresponding HO from TLIF with rhBMP-2 within the disk house between 2002 and 2015.
To doc this complication and enhance its recognition, we recorded frequent patterns of symptom improvement and radiologic findings: particularly, time from implantation of rhBMP-2 to symptom improvement, consistency with aspect of TLIF placement, and radiologic findings. Radicular ache usually developed a imply (SD) of three.8 (1.0) months after TLIF with rhBMP-2.
Growth of radiculopathy signs corresponded to constant “pseudo-pedicle”-like HO. In all 38 sufferers, HO arising from the annulotomy web site confirmed a definite pseudo-pedicle sample encompassing nerve roots and the thecal sac. As well as, improvement of radiculopathy signs and corresponding HO seem like impartial of quantity of rhBMP-2.
HO ensuing from TLIF with rhBMP-2 within the disk house is a ache generator and a recognizable complication that may be recognized by evaluation of signs and computed tomography traits.
IL1F6 ORF Vector (Human) (pORF)
|
Heterozygous PAX6 gene mutations resulting in haploinsufficiency are the principle explanation for congenital aniridia, a uncommon and progressive panocular illness characterised by decreased visible acuity. As much as 90% of sufferers endure from aniridia-related keratopathy (ARK), attributable to a mixture of things together with limbal epithelial stem cell (LSC) deficiency, impaired therapeutic response and irregular differentiation of the corneal epithelium.
It often begins within the first decade of life, leading to recurrent corneal erosions, sub-epithelial fibrosis, and corneal opacification. Sadly, there are at the moment no environment friendly remedies obtainable for these sufferers and no in vitro mannequin for this pathology. We used CRISPR/Cas9 expertise to introduce into the PAX6 gene of LSCs a heterozygous nonsense mutation present in ARK sufferers.
9 clones carrying a p.E109X mutation on one allele have been obtained with no off-target mutations. In contrast with the parental LSCs, heterozygous mutant LSCs displayed decreased expression of PAX6 and marked slow-down of cell proliferation, migration and detachment.
IL1F6 Conjugated Antibody |
C44817 |
SAB |
100ul |
EUR 397 |
IL1F6 ORF Vector (Human) (pORF) |
ORF013344 |
ABM |
1.0 ug DNA |
EUR 95 |
IL1F6 Protein Vector (Human) (pPB-C-His) |
PV053373 |
ABM |
500 ng |
EUR 481 |
IL1F6 Protein Vector (Human) (pPB-N-His) |
PV053374 |
ABM |
500 ng |
EUR 481 |
IL1F6 Protein Vector (Human) (pPM-C-HA) |
PV053375 |
ABM |
500 ng |
EUR 481 |
IL1F6 Protein Vector (Human) (pPM-C-His) |
PV053376 |
ABM |
500 ng |
EUR 481 |
Recombinant Human IL1F6/ IL36 Protein, Untagged, E.coli-100ug |
QP10330-ec-100ug |
EnQuireBio |
100ug |
EUR 1995 |
Recombinant Human IL1F6/ IL36 Protein, Untagged, E.coli-10ug |
QP10330-ec-10ug |
EnQuireBio |
10ug |
EUR 290 |
Recombinant Human IL1F6/ IL36 Protein, Untagged, E.coli-250ug |
QP10330-ec-250ug |
EnQuireBio |
250ug |
EUR 3536 |
Recombinant Human IL1F6/ IL36 Protein, Untagged, E.coli-2ug |
QP10330-ec-2ug |
EnQuireBio |
2ug |
EUR 154 |
Recombinant Human IL1F6/ IL36 Protein, GST, E.coli-100ug |
QP8208-ec-100ug |
EnQuireBio |
100ug |
EUR 408 |
Recombinant Human IL1F6/ IL36 Protein, GST, E.coli-10ug |
QP8208-ec-10ug |
EnQuireBio |
10ug |
EUR 200 |
Recombinant Human IL1F6/ IL36 Protein, GST, E.coli-1mg |
QP8208-ec-1mg |
EnQuireBio |
1mg |
EUR 1632 |
Recombinant Human IL1F6/ IL36 Protein, GST, E.coli-200ug |
QP8208-ec-200ug |
EnQuireBio |
200ug |
EUR 634 |
Recombinant Human IL1F6/ IL36 Protein, GST, E.coli-500ug |
QP8208-ec-500ug |
EnQuireBio |
500ug |
EUR 1060 |
Recombinant Human IL1F6/ IL36 Protein, GST, E.coli-50ug |
QP8208-ec-50ug |
EnQuireBio |
50ug |
EUR 263 |
IL1F6 sgRNA CRISPR Lentivector set (Human) |
K1074101 |
ABM |
3 x 1.0 ug |
EUR 339 |
IL1F6 Protein Vector (Rat) (pPB-C-His) |
PV274422 |
ABM |
500 ng |
EUR 603 |
IL1F6 Protein Vector (Rat) (pPB-N-His) |
PV274423 |
ABM |
500 ng |
EUR 603 |
IL1F6 Protein Vector (Rat) (pPM-C-HA) |
PV274424 |
ABM |
500 ng |
EUR 603 |
IL1F6 Protein Vector (Rat) (pPM-C-His) |
PV274425 |
ABM |
500 ng |
EUR 603 |
IL1F6 Protein Vector (Mouse) (pPB-C-His) |
PV191362 |
ABM |
500 ng |
EUR 603 |
IL1F6 Protein Vector (Mouse) (pPB-N-His) |
PV191363 |
ABM |
500 ng |
EUR 603 |
IL1F6 Protein Vector (Mouse) (pPM-C-HA) |
PV191364 |
ABM |
500 ng |
EUR 603 |
IL1F6 Protein Vector (Mouse) (pPM-C-His) |
PV191365 |
ABM |
500 ng |
EUR 603 |
Il1f6 ORF Vector (Rat) (pORF) |
ORF068606 |
ABM |
1.0 ug DNA |
EUR 506 |
Il1f6 ORF Vector (Mouse) (pORF) |
ORF047841 |
ABM |
1.0 ug DNA |
EUR 506 |
Human Interleukin-36 alpha(IL1F6) ELISA kit |
CSB-EL011617HU-24T |
Cusabio |
1 plate of 24 wells |
EUR 165 |
|
Description: Quantitativesandwich ELISA kit for measuring Human Interleukin-36 alpha (IL1F6) in samples from serum, plasma, tissue homogenates, cell culture supernates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human Interleukin-36 alpha(IL1F6) ELISA kit |
1-CSB-EL011617HU |
Cusabio |
-
EUR 804.00
-
EUR 5099.00
-
EUR 2704.00
|
-
1 plate of 96 wells
-
10 plates of 96 wells each
-
5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Human Interleukin-36 alpha(IL1F6) in samples from serum, plasma, tissue homogenates, cell culture supernates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
IL1F6 sgRNA CRISPR Lentivector (Human) (Target 1) |
K1074102 |
ABM |
1.0 ug DNA |
EUR 154 |
IL1F6 sgRNA CRISPR Lentivector (Human) (Target 2) |
K1074103 |
ABM |
1.0 ug DNA |
EUR 154 |
IL1F6 sgRNA CRISPR Lentivector (Human) (Target 3) |
K1074104 |
ABM |
1.0 ug DNA |
EUR 154 |
Recombinant Mouse IL1F6/ IL36 Protein, Untagged, E.coli-100ug |
QP10465-ec-100ug |
EnQuireBio |
100ug |
EUR 1995 |
Recombinant Mouse IL1F6/ IL36 Protein, Untagged, E.coli-10ug |
QP10465-ec-10ug |
EnQuireBio |
10ug |
EUR 290 |
Recombinant Mouse IL1F6/ IL36 Protein, Untagged, E.coli-250ug |
QP10465-ec-250ug |
EnQuireBio |
250ug |
EUR 3536 |
Recombinant Mouse IL1F6/ IL36 Protein, Untagged, E.coli-2ug |
QP10465-ec-2ug |
EnQuireBio |
2ug |
EUR 154 |
Il1f6 sgRNA CRISPR Lentivector set (Rat) |
K6578501 |
ABM |
3 x 1.0 ug |
EUR 339 |
Il1f6 sgRNA CRISPR Lentivector set (Mouse) |
K3933201 |
ABM |
3 x 1.0 ug |
EUR 339 |
IL1F6 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV815007 |
ABM |
1.0 ug DNA |
EUR 450 |
IL1F6 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV815011 |
ABM |
1.0 ug DNA |
EUR 450 |
IL1F6 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV815012 |
ABM |
1.0 ug DNA |
EUR 450 |
IL1F6 3'UTR Luciferase Stable Cell Line |
TU011019 |
ABM |
1.0 ml |
EUR 2333 |
Il1f6 3'UTR Luciferase Stable Cell Line |
TU110040 |
ABM |
1.0 ml |
Ask for price |
Il1f6 3'UTR GFP Stable Cell Line |
TU160040 |
ABM |
1.0 ml |
Ask for price |
Il1f6 3'UTR Luciferase Stable Cell Line |
TU206220 |
ABM |
1.0 ml |
Ask for price |
Recombinant Human IL1F6/ IL36 Protein, Untagged, E.coli-100ug
|
Furthermore, addition to the tradition medium of recombinant PAX6 protein fused to a cell penetrating peptide was in a position to activate the endogenous PAX6 gene and to rescue phenotypic defects of mutant LSCs, suggesting that administration of such recombinant PAX6 protein might be a promising therapeutic strategy for aniridia-related keratopathy.
Extra usually, our outcomes exhibit that introduction of illness mutations into LSCs by CRISPR/Cas9 genome modifying permits the creation of related mobile fashions of ocular illness that ought to tremendously facilitate screening of novel therapeutic approaches. Stem Cells 2018;36:1421-1429.
Human Interleukin-36 alpha(IL1F6) ELISA package
|
Description: Quantitativesandwich ELISA package for measuring Human Interleukin-36 alpha (IL1F6) in samples from serum, plasma, tissue homogenates, cell tradition supernates.
A brand new trial model of the package, which lets you take a look at the package in your utility at an affordable worth.
|
|
UPK2 Uroplakin 2 Human Recombinant Protein
|
Description: UPK2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 153 amino acids (26-155 a.a) and having a molecular mass of 16.2kDa.;UPK2 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic methods.
|
|
Recombinant Human UPK2 Protein, His, E.coli-1mg |
QP13897-1mg |
EnQuireBio |
1mg |
EUR 2757 |
Recombinant Human UPK2 Protein, His, E.coli-20ug |
QP13897-20ug |
EnQuireBio |
20ug |
EUR 201 |
Recombinant Human UPK2 Protein, His, E.coli-5ug |
QP13897-5ug |
EnQuireBio |
5ug |
EUR 155 |
Recombinant Uroplakin 2 (UPK2) |
4-RPF561Hu01 |
Cloud-Clone |
-
EUR 368.80
-
EUR 202.00
-
EUR 1108.00
-
EUR 436.00
-
EUR 772.00
-
EUR 310.00
-
EUR 2620.00
|
-
100 ug
-
10ug
-
1 mg
-
200 ug
-
500 ug
-
50ug
-
5 mg
|
|
Description: Recombinant Human Uroplakin 2 expressed in: E.coli |
Human Uroplakin 2 (UPK2) Protein |
20-abx650668 |
Abbexa |
-
EUR 523.00
-
EUR 244.00
-
EUR 1497.00
-
EUR 606.00
-
EUR 384.00
|
-
100 ug
-
10 ug
-
1 mg
-
200 ug
-
50 ug
|
|
UPK2 antibody |
70R-21174 |
Fitzgerald |
50 ul |
EUR 435 |
Description: Rabbit polyclonal UPK2 antibody |
UPK2 Antibody |
1-CSB-PA025656GA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against UPK2. Recognizes UPK2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
UPK2 siRNA |
20-abx939075 |
Abbexa |
|
|
|
UPK2 protein (His tag) |
30R-2967 |
Fitzgerald |
100 ug |
EUR 322 |
Description: Purified recombinant Human UPK2 protein (His tag) |
Uroplakin-2 (UPK2) Protein |
20-abx261408 |
Abbexa |
-
EUR 3418.00
-
EUR 328.00
-
EUR 230.00
|
|
|
Recombinant Human Uroplakin-2/UPK2 (C-6His) |
CA11-10ug |
Novoprotein |
10ug |
EUR 202 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human Uroplakin-2/UPK2 (C-6His) |
CA11-1mg |
Novoprotein |
1mg |
EUR 2283 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human Uroplakin-2/UPK2 (C-6His) |
CA11-500ug |
Novoprotein |
500ug |
EUR 1613 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human Uroplakin-2/UPK2 (C-6His) |
CA11-50ug |
Novoprotein |
50ug |
EUR 496 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Human UPK2 shRNA Plasmid |
20-abx955048 |
Abbexa |
|
|
|
UPK2 cloning plasmid |
CSB-CL025656HU-10ug |
Cusabio |
10ug |
EUR 233 |
|
Description: A cloning plasmid for the UPK2 gene. |
UPK2 Rabbit pAb |
A3338-100ul |
Abclonal |
100 ul |
EUR 308 |
UPK2 Rabbit pAb |
A3338-200ul |
Abclonal |
200 ul |
EUR 459 |
UPK2 Rabbit pAb |
A3338-20ul |
Abclonal |
20 ul |
Ask for price |
UPK2 Rabbit pAb |
A3338-50ul |
Abclonal |
50 ul |
Ask for price |
UPK2 Rabbit pAb |
A10813-100ul |
Abclonal |
100 ul |
EUR 308 |
UPK2 Rabbit pAb |
A10813-200ul |
Abclonal |
200 ul |
EUR 459 |
UPK2 Rabbit pAb |
A10813-20ul |
Abclonal |
20 ul |
EUR 183 |
UPK2 Rabbit pAb |
A10813-50ul |
Abclonal |
50 ul |
EUR 223 |
Anti-UPK2 antibody |
STJ26047 |
St John's Laboratory |
100 µl |
EUR 277 |
Description: This gene encodes one of the proteins of the highly conserved urothelium-specific integral membrane proteins of the asymmetric unit membrane which forms urothelium apical plaques in mammals. The asymmetric unit membrane is believed to strengthen the urothelium by preventing cell rupture during bladder distention. The encoded protein is expressed in the peripheral blood of bladder cancer patients with transitional cell carcinomas. |
Anti-UPK2 antibody |
STJ112709 |
St John's Laboratory |
100 µl |
EUR 277 |
Description: This gene encodes one of the proteins of the highly conserved urothelium-specific integral membrane proteins of the asymmetric unit membrane which forms urothelium apical plaques in mammals. The asymmetric unit membrane is believed to strengthen the urothelium by preventing cell rupture during bladder distention. The encoded protein is expressed in the peripheral blood of bladder cancer patients with transitional cell carcinomas. |
UPK2 Polyclonal Antibody |
27504-100ul |
SAB |
100ul |
EUR 252 |
UPK2 Polyclonal Antibody |
27504-50ul |
SAB |
50ul |
EUR 187 |
anti- UPK2 antibody |
FNab09274 |
FN Test |
100µg |
EUR 548.75 |
|
Description: Antibody raised against UPK2 |
anti- UPK2 antibody |
FNab09275 |
FN Test |
100µg |
EUR 585 |
|
Description: Antibody raised against UPK2 |
UPK2 ORF Vector (Human) (pORF) |
ORF014895 |
ABM |
1.0 ug DNA |
EUR 354 |
UPK2 ELISA Kit (Human) (OKAN06386) |
OKAN06386 |
Aviva Systems Biology |
96 Wells |
EUR 792 |
Description: Description of target: This gene encodes one of the proteins of the highly conserved urothelium-specific integral membrane proteins of the asymmetric unit membrane which forms urothelium apical plaques in mammals. The asymmetric unit membrane is believed to strengthen the urothelium by preventing cell rupture during bladder distention. The encoded protein is expressed in the peripheral blood of bladder cancer patients with transitional cell carcinomas.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.053 ng/mL |
UPK2 ELISA Kit (Human) (OKCD00470) |
OKCD00470 |
Aviva Systems Biology |
96 Wells |
EUR 831 |
Description: Description of target: Component of the asymmetric unit membrane (AUM); a highly specialized biomembrane elaborated by terminally differentiated urothelial cells. May play an important role in regulating the assembly of the AUM (By similarity).By similarity ;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: < 0.053 ng/mL |
UPK2 Protein Vector (Human) (pPB-C-His) |
PV059577 |
ABM |
500 ng |
EUR 481 |
UPK2 Protein Vector (Human) (pPB-N-His) |
PV059578 |
ABM |
500 ng |
EUR 481 |
UPK2 Protein Vector (Human) (pPM-C-HA) |
PV059579 |
ABM |
500 ng |
EUR 481 |
UPK2 Protein Vector (Human) (pPM-C-His) |
PV059580 |
ABM |
500 ng |
EUR 481 |
Mouse Uroplakin-2 (Upk2) |
1-CSB-EP025656MO |
Cusabio |
-
EUR 505.00
-
EUR 265.00
-
EUR 1827.00
-
EUR 766.00
-
EUR 1218.00
-
EUR 335.00
|
-
100ug
-
10ug
-
1MG
-
200ug
-
500ug
-
50ug
|
|
Description: Recombinant Mouse Uroplakin-2(Upk2) expressed in E.coli |
Uroplakin-2 (UPK2) Antibody |
20-abx126762 |
Abbexa |
-
EUR 411.00
-
EUR 592.00
-
EUR 182.00
-
EUR 314.00
|
-
100 ul
-
200 ul
-
20 ul
-
50 ul
|
|
Uroplakin 2 (UPK2) Antibody |
20-abx116547 |
Abbexa |
|
|
|
Uroplakin-2 (UPK2) Antibody |
abx239274-100ug |
Abbexa |
100 ug |
EUR 509 |
|
Uroplakin-2 (UPK2) Antibody |
20-abx002383 |
Abbexa |
|
|
|
Uroplakin 2 (UPK2) Antibody |
20-abx131673 |
Abbexa |
-
EUR 453.00
-
EUR 133.00
-
EUR 1302.00
-
EUR 620.00
-
EUR 342.00
|
-
100 ug
-
10 ug
-
1 mg
-
200 ug
-
50 ug
|
|
UPK2 Polyclonal Conjugated Antibody |
C27504 |
SAB |
100ul |
EUR 397 |
Uroplakin 2 (UPK2) Polyclonal Antibody (Human) |
4-PAF561Hu01 |
Cloud-Clone |
-
EUR 261.00
-
EUR 2734.00
-
EUR 676.00
-
EUR 330.00
-
EUR 220.00
|
-
100ul
-
10ml
-
1ml
-
200ul
-
20ul
|
|
Description: A Rabbit polyclonal antibody against Human Uroplakin 2 (UPK2) |
Human Uroplakin 2 (UPK2) ELISA Kit |
SEF561Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 4731.5 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Uroplakin 2 (UPK2) in tissue homogenates, cell lysates and other biological fluids. |
Human Uroplakin 2 (UPK2) ELISA Kit |
SEF561Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 477.3 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Uroplakin 2 (UPK2) in tissue homogenates, cell lysates and other biological fluids. |
Human Uroplakin 2 (UPK2) ELISA Kit |
SEF561Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 639 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Uroplakin 2 (UPK2) in tissue homogenates, cell lysates and other biological fluids. |
Human Uroplakin 2 (UPK2) ELISA Kit |
SEF561Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 2575.5 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Uroplakin 2 (UPK2) in tissue homogenates, cell lysates and other biological fluids. |
Human Uroplakin 2 (UPK2) ELISA Kit |
4-SEF561Hu |
Cloud-Clone |
-
EUR 4782.00
-
EUR 2526.00
-
EUR 640.00
|
-
10 plates of 96 wells
-
5 plates of 96 wells
-
1 plate of 96 wells
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Uroplakin 2 (UPK2) in samples from tissue homogenates, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species. |
UPK2 sgRNA CRISPR Lentivector set (Human) |
K2591901 |
ABM |
3 x 1.0 ug |
EUR 339 |
Human Uroplakin 2 (UPK2) CLIA Kit |
20-abx494951 |
Abbexa |
-
EUR 7973.00
-
EUR 4246.00
-
EUR 981.00
|
-
10 × 96 tests
-
5 × 96 tests
-
96 tests
|
|
Human Uroplakin 2 (UPK2) ELISA Kit |
20-abx156911 |
Abbexa |
-
EUR 7378.00
-
EUR 3933.00
-
EUR 911.00
|
-
10 × 96 tests
-
5 × 96 tests
-
96 tests
|
|
Human Uroplakin 2 ELISA Kit (UPK2) |
RK02481 |
Abclonal |
96 Tests |
EUR 521 |
UPK2 Protein Vector (Mouse) (pPB-C-His) |
PV244278 |
ABM |
500 ng |
EUR 603 |
UPK2 Protein Vector (Mouse) (pPB-N-His) |
PV244279 |
ABM |
500 ng |
EUR 603 |
UPK2 Protein Vector (Mouse) (pPM-C-HA) |
PV244280 |
ABM |
500 ng |
EUR 603 |
UPK2 Protein Vector (Mouse) (pPM-C-His) |
PV244281 |
ABM |
500 ng |
EUR 603 |
UPK2 Protein Vector (Rat) (pPB-C-His) |
PV314586 |
ABM |
500 ng |
EUR 603 |
UPK2 Protein Vector (Rat) (pPB-N-His) |
PV314587 |
ABM |
500 ng |
EUR 603 |
UPK2 Protein Vector (Rat) (pPM-C-HA) |
PV314588 |
ABM |
500 ng |
EUR 603 |
UPK2 Protein Vector (Rat) (pPM-C-His) |
PV314589 |
ABM |
500 ng |
EUR 603 |
Upk2 ORF Vector (Mouse) (pORF) |
ORF061070 |
ABM |
1.0 ug DNA |
EUR 506 |